Delving into the Latest Updates on Autologous bone marrow stem cell(Manipal Acunova) with Synapse

Overview

Basic Info

Drug Type

Stem cell therapy

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Nervous System DiseasesCardiovascular Diseases

Active Indication-

Inactive Indication

Acute Ischemic Stroke

Originator Organization

Manipal Acunova Ltd.

Active Organization-

Inactive Organization

Manipal Acunova Ltd.

License Organization-

Drug Highest PhasePendingPhase 2

First Approval Date-

Regulation-

A multi-centric initiative to study safety,feasibility and efficacy of using intravenous autologous bone marrow mononuclear cells(BMMC) in patients with acute ischemic stroke.This phase of study is visualised as phase 2 study and will aim to determine dose response gradient of stem cell therapy and to explore if there is favorable risk to benefit ratio for autologous stem cell therapy in patient with acute ischamic stroke.

Start Date01 Oct 2008

Sponsor / Collaborator

Manipal Acunova Ltd.

[+1]

100 Clinical Results associated with Autologous bone marrow stem cell(Manipal Acunova)

Login to view more data

100 Translational Medicine associated with Autologous bone marrow stem cell(Manipal Acunova)

Login to view more data

100 Patents (Medical) associated with Autologous bone marrow stem cell(Manipal Acunova)

Login to view more data

100 Deals associated with Autologous bone marrow stem cell(Manipal Acunova)

Login to view more data